NDC 0024-5922 – Kevzara
Sarilumab 200 mg/1.14mL · Injection, Solution · Subcutaneous
Product NDC0024-5922
Product details
- Brand name
- Kevzara
- Generic name
- Sarilumab
- Labeler
- Sanofi-Aventis U.S. LLC
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761037
- Marketed since
- May 22, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-6 Receptor Antagonist
Active ingredients
- Sarilumab 200 mg/1.14mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0024-5922-01 | 2 SYRINGE in 1 PACKAGE (0024-5922-01) / 1.14 mL in 1 SYRINGE (0024-5922-00) | Apr 13, 2018 |
| 0024-5922-02 | 2 SYRINGE in 1 PACKAGE (0024-5922-02) / 1.14 mL in 1 SYRINGE | Apr 13, 2018 |